Navigation Links
Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
Date:5/1/2013

RICHMOND, Calif., May 1, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2013 financial results on Wednesday, May 8, 2013, after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

The conference call dial-in numbers are 877-377-7553 for domestic callers and 678-894-3968 for international callers. The passcode for the call is 52754725.  Participants may access the live webcast via a link on the Sangamo BioSciences website in the Investors section under "Events and Presentations" http://investor.sangamo.com/events.cfm. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on May 8, 2013 to 11:59 p.m. ET on May 15, 2013. The conference call replay numbers for domestic and international callers are 855-859-2056 and 404-537-3406, respectively. The conference ID number for the replay is 52754725.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and  hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia and other monogenic diseases and has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
2. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
3. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
4. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
5. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
6. CytoVas And BD Biosciences Ink Alliance To Co-Develop Personalized Diagnostic For Vascular Health
7. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
8. Chipscreen Biosciences Announces Achievement of Primary Endpoint in Chidamide Registrational Trial in China
9. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
10. Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
11. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2020)... KILLINGTON, Vt. (PRWEB) , ... January 11, 2020 , ... ... more beneficial than a regular vacation and information on how to book an affordable ... opportunity to get away from the frenetic pace of everyday life, sight see and ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... for radiology and the healthcare industry — today announced the appointment of Connie ... of industry experience, working with health systems in sales and marketing leadership roles. ...
(Date:1/10/2020)... ... January 10, 2020 , ... Allegheny Health Network (AHN) and ... GCMC into the family of hospitals affiliated with and operated by the Pittsburgh-based ... patients with a vital new access point for high-quality acute care services between ...
Breaking Medicine Technology:
(Date:1/10/2020)... ... January 10, 2020 , ... NW Women’s Fitness ... non-intimidating environment for all women. In search for a valuable nutrition solution, NW ... members. , For nearly 30 years, Balanced Habits, headquartered in Southern California, ...
(Date:1/8/2020)... ... January 08, 2020 , ... Mirror ... Magazine’s 2019 Best of Memorial Readers’ Choice Awards. Located adjacent to ... named Best MedSpa in Memorial reflects Mirror Mirror Beauty Boutique’s commitment to the ...
(Date:1/7/2020)... ... 07, 2020 , ... G-CON Manufacturing, the leader in prefabricated, ... sq. ft. manufacturing site in College Station, TX. The new facility, opening January ... mechanical, electrical and automation fit out. , “This facility allows us to grow ...
(Date:1/7/2020)... ... 2020 , ... CBD For The People was created with the ... the individual customer service experience. Transparency and integrity are the core of this company. ... taking care of the people first, they know that satisfied customers will bring back ...
(Date:1/7/2020)... Fla. (PRWEB) , ... January 06, 2020 , ... ... older adults living with memory impairment, has announced the Best Memory Care Facilities ... access to experts, facility features and amenities. , According to the ...
Breaking Medicine News(10 mins):